Mounjaro (Tirzepatide) is an injectable prescription medication used alongside diet and exercise to improve blood sugar levels in adults with type 2 diabetes mellitus.

Why Choose Mounjaro (Tirzepatide)?

Mounjaro (Tirzepatide) is a treatment option for adults with type 2 diabetes when diet and exercise alone do not control blood sugar levels adequately. It is the first and only GIP and GLP-1 receptor agonist medication that activates natural incretin hormones to regulate blood sugar levels. In clinical trials, it has been shown to deliver superior A1C reductions, and for eligible patients, it can also support weight loss efforts​.

How to Use Mounjaro (Tirzepatide)?

Mounjaro is an injectable medication prescribed for adults with type 2 diabetes to help manage their blood sugar levels. To ensure safe and effective use, patients should:

• Read the Medication Guide and Instructions For Use provided by their pharmacist before starting and each time they get a refill.
• Administer Mounjaro as a subcutaneous injection once a week, using the single-dose pen which comes in various dosages: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per 0.5 mL.
• Start with a 2.5 mg dose once a week for the first four weeks, then potentially increase to 5 mg per week depending on the doctor’s advice. Dosage adjustments should be made in 2.5-mg increments after at least 4 weeks at the current dose, with a maximum dose of 15 mg weekly.
• Check the product visually for particles or discoloration before use.
• Follow any specific preparation and usage instructions provided by healthcare professionals.
• Mounjaro should be used in conjunction with a proper diet and exercise regimen.
• It is not suitable for individuals with type 1 diabetes or those who have had pancreatitis.